ES2059392T3 - Etodolac para la inhibicion de la anquilosis de las articulaciones. - Google Patents

Etodolac para la inhibicion de la anquilosis de las articulaciones.

Info

Publication number
ES2059392T3
ES2059392T3 ES87309257T ES87309257T ES2059392T3 ES 2059392 T3 ES2059392 T3 ES 2059392T3 ES 87309257 T ES87309257 T ES 87309257T ES 87309257 T ES87309257 T ES 87309257T ES 2059392 T3 ES2059392 T3 ES 2059392T3
Authority
ES
Spain
Prior art keywords
joints
anchylosis
etodolac
inhibition
ethodolac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87309257T
Other languages
English (en)
Inventor
Paul Hastings Wooley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Application granted granted Critical
Publication of ES2059392T3 publication Critical patent/ES2059392T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE DESCRIBE UN METODO PARA INHIBIR LA ANQUILOSIS DE LAS ARTICULACIONES EN EL TRATAMIENTO DE LOS ARTRITICOS POR ADMINISTRACION DE UNA CANTIDAD EFICAZ DE ETODOLAC.
ES87309257T 1986-10-27 1987-10-20 Etodolac para la inhibicion de la anquilosis de las articulaciones. Expired - Lifetime ES2059392T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/923,373 US4710511A (en) 1986-10-27 1986-10-27 Etodolac for inhibition of joint ankylosis

Publications (1)

Publication Number Publication Date
ES2059392T3 true ES2059392T3 (es) 1994-11-16

Family

ID=25448579

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87309257T Expired - Lifetime ES2059392T3 (es) 1986-10-27 1987-10-20 Etodolac para la inhibicion de la anquilosis de las articulaciones.

Country Status (8)

Country Link
US (1) US4710511A (es)
EP (1) EP0266114B1 (es)
JP (1) JP2585638B2 (es)
KR (1) KR950013755B1 (es)
AT (1) ATE96666T1 (es)
DE (1) DE3788035T2 (es)
DK (1) DK559487A (es)
ES (1) ES2059392T3 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533551A (en) * 1984-02-17 1985-08-06 American Home Products Corporation Method of treating arthritis with etodolac

Also Published As

Publication number Publication date
JPS63126822A (ja) 1988-05-30
KR950013755B1 (ko) 1995-11-15
JP2585638B2 (ja) 1997-02-26
KR880004813A (ko) 1988-06-27
ATE96666T1 (de) 1993-11-15
DE3788035T2 (de) 1994-03-03
DE3788035D1 (de) 1993-12-09
DK559487A (da) 1988-04-28
EP0266114B1 (en) 1993-11-03
US4710511A (en) 1987-12-01
EP0266114A3 (en) 1990-05-09
EP0266114A2 (en) 1988-05-04
DK559487D0 (da) 1987-10-26

Similar Documents

Publication Publication Date Title
BG60249B1 (bg) Тиазолово съединение за лечение на язви
FI865269A (fi) Kvaevehaltiga heterocykliska foereningar.
FI93350C (fi) Menetelmä uusien farmakologisesti aktiivisten katekolijohdoksien valmistamiseksi
MX164474B (es) PROCEDIMIENTO PARA EL CRECIMIENTO DE CRISTAL DE MTiOXO4 DE UNA SOLUCION
ES2160897T3 (es) Pirazoles como inhibidores de la secretora fosfolipasa a2 humana no pancreatica.
ES536281A0 (es) Una maquina para el tratamiento de suelos
AT385036B (de) Verfahren zum herstellen von neuen carboxamidoderivaten von 5h-1,3,4-thiadiazolo(3,2-a)-pyrimidinen und ihren pharmazeutisch unbedenklichen salzen
ES2059301T3 (es) Utilizacion de inhibidores de la enzima convertidora de angiotensina para el tratamiento de la aterosclerosis, trombosis y de la enfermedad vascular periferica.
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
ES530983A0 (es) Procedimiento para determinar el tiempo de tromboplastina parcial activado
ES2017764B3 (es) Procedimiento para el tratamiento de celulas primarias utilizadas
IT8149328A0 (it) Medicamenti a base di inibitori della secrezione della prolactina per il trattamento dell'arterioscle rosi
ES2059392T3 (es) Etodolac para la inhibicion de la anquilosis de las articulaciones.
MX26167A (es) Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino.
ES2174034T3 (es) Naftilglioxamidas como inhibidores de spla2
ATE162717T1 (de) Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten
ES539242A0 (es) Maquina movil para excavar el balasto de las vias ferreas
ES554903A0 (es) Disposicion para el tratamiento de piezas de trabajo
IT8621384A1 (it) Metodo per il trattamento di lenti a contatto
FR2392966A1 (fr) Nouveaux acides uree-bis(naphtalene-sulfoniques et naphtalene-carboxyliques), leurs sels pharmaceutiquement acceptables, et leur utilisation therapeutique
ES519080A0 (es) Un metodo para producir una composicion oleosa de un farmaco antitumoral.
DE3650221D1 (de) Penemderivate.
SU659575A1 (ru) Способ получени флокул нта дл осветлени поверхностных вод
ES8504144A1 (es) Un procedimiento para la preparacion de una 5-(2-alcoxi-fenil 3-sustituido)hidantoina
ES544029A0 (es) Un metodo para el tratamiento de un rodillo de trabajo rotativo de un laminador o analogos para trabajar una pieza.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 266114

Country of ref document: ES